Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Proc Natl Acad Sci U S A. 2012 11-Apr;():. 10.1073/pnas.1119598109A prospective, within-patient study examined the effects of psilocybin on arterial spin labelling (ASL) and blood-oxygen level dependent (BOLD) fMRI, as well as subjective ratings of drug effects. Each patient was scanned prior to drug administration, and after an intravenous infusion of 2 mg of psilocybin. Fifteen patients were scanned using ASL and fifteen using BOLD. Patients reported profound changes in subjective evaluations of drug effects. ASL and BOLD showed only decreases in cerebral blood flow after psilocybin administration, with no areas of increased activity. The major areas seeing decreases were the thalamus, anterior and posterior cingulate cortex and medial prefrontal cortex.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics